Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Topical Pramoxine Compositions - Happi
Patents

Topical Pramoxine Compositions

GlaxoSmithKline Consumer Healthcare is awarded a patent for a formulation with an ingredient used to temporarily relieve pain and itching.

US Patent No. 11,510,856 B2 (Pallav Arvind Bulsara, Martyn J. Clarke, Dara Lisa Dinner, Alireza Shalviri); GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, New Castle, DE has patented a topical oil-in-water emulsion composition. It is comprised of discontinuous oil phase comprising hydrogenated castor oil, mineral oil, and caprylic/capric triglyceride; a continuous aqueous phase comprising water and  glycerine; a thickening agent; at least one lamellar membrane structure comprising phospholipid component comprising hydrogenated phosphatidylcholine, a fatty alcohol component comprising behenyl alcohol or a mixture of behenyl alcohol and cetyl alcohol, a fatty acid component comprising behenic acid, and a branched fatty acid and a branched fatty alcohol component comprising isostearylisostearate; pramoxine, optionally as the pharmaceutically acceptable salt; and;  optionally a dermatologically acceptable excipient. The composition has a water vapor transmission rate of less than about 65 gm−2 hr−1 measured in vitro using the modWVTR test methodology.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters